Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms.

Department of Nutrition, Exercise, and Health Science, Central Washington University, Ellensburg, WA, USA.
Advances in Nutrition (Impact Factor: 3.2). 01/2012; 3(1):39-46. DOI: 10.3945/an.111.001271
Source: PubMed

ABSTRACT Epidemiological studies beginning in the 1990s have reported that intake of quercetin, a polyphenolic flavonoid found in a wide variety of plant-based foods, such as apples, onions, berries, and red wine, is inversely related to cardiovascular disease. More recent work using hypertensive animals and humans (>140 mm Hg systolic and >90 mm Hg diastolic) indicates a decrease in blood pressure after quercetin supplementation. A number of proposed mechanisms may be responsible for the observed blood pressure decrease such as antioxidant effects, inhibition of angiotensin-converting enzyme activity, and improved endothelium-dependent and -independent function. The majority of these mechanisms have been identified using animal models treated with quercetin, and relatively few have been corroborated in human studies. The purpose of this review is to examine the evidence supporting the role of quercetin as a potential therapeutic agent and the mechanisms by which quercetin might exert its blood pressure-lowering effect.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cross-matching of toxicological, clinical and other data improves risk analysis.•Induction of drug metabolism is linked to increased cell proliferation.•Rodents and man have differences in metabolism of Ginkgo biloba.•Controlled clinical data did not reveal any serious or specific adverse drug reaction.•Cross-matching of various sources gives strong evidence that Ginkgo biloba is safe.
    Toxicology 11/2014; · 3.75 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The food supplement quercetin is used as self-medication for prostate disorders and is known to induce vasorelaxation. The drug tamsulosin is used in the treatment of benign prostatic hyperplasia. A major side effect of tamsulosin is orthostatic hypotension, mediated by vasorelaxation resulting from α1-adrenoceptor blockade. The overlapping profile prompted us to investigate the pharmacodynamic interaction of quercetin with tamsulosin. Since quercetin is extensively metabolized in the intestines and the liver, the metabolites quercetin-3-glucuronide and 4'O-methyl-quercetin were also examined. Vasorelaxation induced by the compounds was tested in rat mesenteric arteries (average diameter: 360±μm) constricted by the α1-adrenoceptor agonist phenylephrine. Tamsulosin (0.1nM) decreased phenylephrine sensitivity 17-fold (n=10). Quercetin (5, 10 and 20µM) also caused a decrease (2-, 4- and 6-fold respectively) of phenylephrine sensitivity, while 10µM of quercetin-3-glucuronide and 4'O-methyl-quercetin decreased this sensitivity (1.5- and 2-fold) only slightly (n=6). The combination of tamsulosin with quercetin or quercetin metabolites proved to be far more potent than the compounds in isolation. The combination of quercetin, quercetin-3-glucuronide or 4'O-methyl-quercetin with tamsulosin decreased the phenylephrine sensitivity approximately 200-, 35- and 150-fold (n=6). The strong pharmacodynamic interaction between the food supplement quercetin and tamsulosin underlines the potential of the impact of supplement-drug interactions that warrant more research. Copyright © 2014 Elsevier B.V. All rights reserved.
    European Journal of Pharmacology 11/2014; 746C:132-137. · 2.68 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Reactive oxygen and nitrogen species (RONS) are involved in deleterious/beneficial biological processes. The present study sought to investigate the capacity of single and combinatorial herbal formulations of Acanthus montanus, Emilia coccinea, Hibiscus rosasinensis and Asystasia gangetica to act as superoxide radicals (SOR), hydrogen peroxide (HP), nitric oxide radicals (NOR), hydroxyl radicals (HR) and DPPH radicals antagonists using in vitro models. The herbal extracts were consisted of single herbal formulations (SHfs), double herbal formulations (DHfs), triple herbal formulations (THfs) and quadruple herbal formulation (QHf). Phytochemical composition of the herbal extracts and radical scavenging capacity index (SCI) of the herbal formulations were measured by standard methods. The flavonoids were the most abundant phytochemicals present in the herbal extracts. The SCI50 defined the concentration (µg/mL) of herbal formulation required to scavenge 50% of the investigated radicals. The SHfs, DHfs, THfs and QHf SCI50 against the radicals followed the same order: HR > SOR > DPPH radicals > HP > NOR. Although the various herbal formulations exhibited ambivalent antioxidant activities in terms of their radical scavenging capabilities, a broad survey of results of the present study showed that combinatorial herbal formulations (DHfs, THfs, and QHf) appeared to exhibit lower radical scavenging capacities than those of the SHfs in vitro.
    Journal of Traditional and Complementary Medicine. 10/2015; 2015(2014):e1-e7.


1 Download
Available from